Modeling Host-Virus Interactions in Viral Infectious Diseases Using Stem-Cell-Derived Systems and CRISPR/Cas9 Technology

被引:19
|
作者
Kim, Jihoon [1 ]
Koo, Bon-Kyoung [1 ]
Yoon, Ki-Jun [2 ]
机构
[1] Austrian Acad Sci IMBA, Vienna Bioctr VBC, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria
[2] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 34141, South Korea
来源
VIRUSES-BASEL | 2019年 / 11卷 / 02期
基金
欧洲研究理事会; 新加坡国家研究基金会;
关键词
organoid; host-virus interactions; CRISPR; Cas9 genome editing; induced pluripotent stem cell; adult stem cell; modeling of viral pathogenesis; LONG-TERM CULTURE; ZIKA-VIRUS; CEREBRAL ORGANOIDS; ROTAVIRUS INFECTION; NEURAL PROGENITORS; HUMAN NOROVIRUSES; DRUG-RESISTANCE; CRISPR-CAS9; IDENTIFICATION; NEUROGENESIS;
D O I
10.3390/v11020124
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Pathologies induced by viral infections have undergone extensive study, with traditional model systems such as two-dimensional (2D) cell cultures and in vivo mouse models contributing greatly to our understanding of host-virus interactions. However, the technical limitations inherent in these systems have constrained efforts to more fully understand such interactions, leading to a search for alternative in vitro systems that accurately recreate in vivo physiology in order to advance the study of viral pathogenesis. Over the last decade, there have been significant technological advances that have allowed researchers to more accurately model the host environment when modeling viral pathogenesis in vitro, including induced pluripotent stem cells (iPSCs), adult stem-cell-derived organoid culture systems and CRISPR/Cas9-mediated genome editing. Such technological breakthroughs have ushered in a new era in the field of viral pathogenesis, where previously challenging questions have begun to be tackled. These include genome-wide analysis of host-virus crosstalk, identification of host factors critical for viral pathogenesis, and the study of viral pathogens that previously lacked a suitable platform, e.g., noroviruses, rotaviruses, enteroviruses, adenoviruses, and Zika virus. In this review, we will discuss recent advances in the study of viral pathogenesis and host-virus crosstalk arising from the use of iPSC, organoid, and CRISPR/Cas9 technologies.
引用
收藏
页数:17
相关论文
共 48 条
  • [31] Targeted gene therapy in human-induced pluripotent stem cells from a patient with primary hyperoxaluria type 1 using CRISPR/Cas9 technology
    Esteve, Julie
    Blouin, Jean-Marc
    Lalanne, Magalie
    Azzi-Martin, Lamia
    Dubus, Pierre
    Bidet, Audrey
    Harambat, Jerome
    Llanas, Brigitte
    Moranvillier, Isabelle
    Bedel, Aurelie
    Moreau-Gaudry, Francois
    Richard, Emmanuel
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 517 (04) : 677 - 683
  • [32] Targeted Editing of the pp38 Gene in Marek's Disease Virus-Transformed Cell Lines Using CRISPR/Cas9 System
    Zhang, Yaoyao
    Luo, Jun
    Tang, Na
    Teng, Man
    Reddy, Vishwanatha R. A. P.
    Moffat, Katy
    Shen, Zhiqiang
    Nair, Venugopal
    Yao, Yongxiu
    VIRUSES-BASEL, 2019, 11 (05):
  • [33] Non-viral Gene Disruption by CRISPR/Cas9 Delivery Using Cell-permeable and Protein-stabilizing 30Kc19 Protein
    Yu Jin Kim
    Hyelim Lee
    Hyeonjin Cha
    Ju Hyun Park
    Biotechnology and Bioprocess Engineering, 2020, 25 : 724 - 733
  • [34] A novel cell line generated using the CRISPR/Cas9 technology as universal quality control material for KRAS G12V mutation testing
    Jia, Shiyu
    Zhang, Rui
    Lin, Guigao
    Peng, Rongxue
    Gao, Peng
    Han, Yanxi
    Fu, Yu
    Ding, Jiansheng
    Wu, Qisheng
    Zhang, Kuo
    Xie, Jiehong
    Li, Jinming
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2018, 32 (05)
  • [35] MESENCHYMAL STROMA CELL-DERIVED EXTRACELLULAR VESICLES SHOW ALTERED FUNCTIONALITY AFTER KNOCK OUT OF GENES RELATED TO IMMUNOMODULATORY CAPACITY USING CRISPR/CAS9
    Tertel, T.
    Lutticke, A. L.
    Dittrich, R.
    Giebel, B.
    CYTOTHERAPY, 2023, 25 (06) : S121 - S121
  • [36] CRISPR/Cas9 Gene editing of RyR2 in human stem cell-derived cardiomyocytes provides a novel approach in investigating dysfunctional Ca2+ signaling
    Wei, Hua
    Zhang, Xiao-Hua
    Clift, Cassandra
    Yamaguchi, Naohiro
    Morad, Martin
    CELL CALCIUM, 2018, 73 : 104 - 111
  • [37] Correction of Ito in human induced pluripotent stem Cell-derived cardiomyocyte carrying DPP6 mutation in early repolarization syndrome by CRISPR/Cas9 genome editing
    Wu, Yang
    Kong, Xiang -Jun
    Ji, Ying-Ying
    Fan, Jun
    Chen, Xu-Miao
    Ji, Cheng- Cheng
    Cheng, Yun-Jiu
    Wu, Su-Hua
    EXPERIMENTAL CELL RESEARCH, 2024, 435 (02)
  • [38] Robust aptamer-targeted CRISPR/Cas9 delivery using mesenchymal stem cell membrane -liposome hybrid: BIRC5 gene knockout against melanoma
    Ghaemi, Asma
    Abnous, Khalil
    Taghdisi, Seyed Mohammad
    Vakili-Azghandi, Masoumeh
    Ramezani, Mohammad
    Alibolandi, Mona
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2024, 62
  • [39] Simultaneous construction strategy using two types of fluorescent markers for HVT vector vaccine against infectious bursal disease and H9N2 avian influenza virus by NHEJ-CRISPR/Cas9
    Zhang, Jun-Feng
    Shang, Ke
    Kim, Sang-Won
    Park, Jong-Yeol
    Wei, Bai
    Jang, Hyung-Kwan
    Kang, Min
    Cha, Se-Yeoun
    FRONTIERS IN VETERINARY SCIENCE, 2024, 11
  • [40] Deciphering the Nature of Trp73 Isoforms in Mouse Embryonic Stem Cell Models: Generation of Isoform-Specific Deficient Cell Lines Using the CRISPR/Cas9 Gene Editing System
    Lopez-Ferreras, Lorena
    Martinez-Garcia, Nicole
    Maeso-Alonso, Laura
    Martin-Lopez, Marta
    Diez-Matilla, Angela
    Villoch-Fernandez, Javier
    Alonso-Olivares, Hugo
    Marques, Margarita M.
    Marin, Maria C.
    CANCERS, 2021, 13 (13)